2019
DOI: 10.1002/lrh2.10187
|View full text |Cite
|
Sign up to set email alerts
|

Cross‐Network Directory Service: Infrastructure to enable collaborations across distributed research networks

Abstract: Introduction Existing large‐scale distributed health data networks are disconnected even as they address related questions of healthcare research and public policy. This paper describes the design and implementation of a fully functional prototype open‐source tool, the Cross‐Network Directory Service (CNDS), which addresses much of what keeps distributed networks disconnected from each other. Methods The set of services needed to implement a Cross‐Directory Service was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…However, the recent advances in common data models to create platforms allowing international collaborations across different databases at a regional scale, such as the Exploring and Understanding Adverse Drug Reactions (EU‐ADR) project, the Observational Medical Outcomes Partnership (OMOP) experiment, or the Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium (PROTECT) will allow sufficient power to be reached to study rare diseases. 38 , 39 , 40 , 41 In addition, the methodological improvements in pharmacoepidemiological methodology to generate signals from healthcare databases or for risk quantification, notably through case‐based methods, may in the future make it possible to study rare ADR. 42 , 43 , 44 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, the recent advances in common data models to create platforms allowing international collaborations across different databases at a regional scale, such as the Exploring and Understanding Adverse Drug Reactions (EU‐ADR) project, the Observational Medical Outcomes Partnership (OMOP) experiment, or the Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium (PROTECT) will allow sufficient power to be reached to study rare diseases. 38 , 39 , 40 , 41 In addition, the methodological improvements in pharmacoepidemiological methodology to generate signals from healthcare databases or for risk quantification, notably through case‐based methods, may in the future make it possible to study rare ADR. 42 , 43 , 44 …”
Section: Discussionmentioning
confidence: 99%
“…Adverse Drug Reactions (EU-ADR) project, the Observational Medical Outcomes Partnership (OMOP) experiment, or the Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium (PROTECT) will allow sufficient power to be reached to study rare diseases. [38][39][40][41] In addition, the methodological improvements in pharmacoepidemiological methodology to generate signals from healthcare databases or for risk quantification, notably through case-based methods, may in the future make it possible study rare ADR. [42][43][44] The ICSRs aggregated in the WHO pharmacovigilance database are spontaneously reported by healthcare professionals and patients in 134 countries around the world.…”
Section: Dasatinibmentioning
confidence: 99%
“…Firstly, crossfunctional collaborations can bridge gaps in healthcare delivery by fostering a culture of knowledge sharing and mutual learning. For instance, the Cross-Network Directory Service (CNDS) was developed as an open-source tool to enable collaborations across distributed research networks, aiming to address the disconnection between large-scale distributed health data networks (Malenfant et al, 2019). Such tools and platforms facilitate the seamless sharing of data and insights, leading to more informed decision-making in patient care and research.…”
Section: Introduction 11 Background Of Nigeria's Healthcare Sectormentioning
confidence: 99%
“…Nonetheless, there are five limitations that induce disconnection and impede collaboration across networks or countries: 1) variance in governance policies and participation requirements between networks; 2) the lack of mechanism for broadcasting research capabilities or encouraging accessibility among participants; 3) a lack of security and reliability between networks for data requests and tracking response activity; 4) the absence of operational standards for describing data, which could allow for judgement of fitness-for-use of others’ data sources; and 5) the unavailability of reliable mechanisms for executing queries sent across networks. 5 …”
Section: Introductionmentioning
confidence: 99%